N3C Domain Team: Kidney Disease

Mission

The Kidney Disease Clinical Domain Team aims to investigate risk factors associated with kidney injury and recovery, as well as use of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) in kidney disease. Their research involves the assessment of risk factors, predictors, duration, dialysis need and timing, clinical measures, and interventions for COVID-19-related complications of the kidney. The team also collaborates with other nephrology domain experts.

Team meets every Wednesday at 4:00 PM ET. Please email n3c-tt-akiarbace@googlegroups.com to be added to the calendar invite.


Join the Team!

First Time Users: To get started with N3C and gain access to the N3C Data Enclave, please view the Researcher Essentials webpage.
For Questions or Comments: Please access the N3C Support Desk and click on "Request Domain Team Support".
Google Drive:
Kidney Disease Drive
Google Group:
n3c-tt-akiarbace@googlegroups.com
Slack Channel:
Join the Conversation

Leadership

Sandeep Mallipattu, MD, FASN
Stony Brook Medicine
Richard Moffitt, PhD
Stony Brook Medicine
Farrukh Koraishy, MD, PhD, FASN
Stony Brook University Hospital

To Cite the N3C: "The analyses described in this [publication/report/presentation] were conducted with data or tools accessed through the NCATS N3C Data Enclave https://covid.cd2h.org and N3C Attribution & Publication Policy v 1.2-2020-08-25b supported by NCATS Contract No. 75N95023D00001 and [insert additional funding agencies or sources and reference numbers as declared by the contributors in their form response above]. This research was possible because of the patients whose information is included within the data and the organizations (https://ncats.nih.gov/n3c/resources/data-contribution/data-transfer-agreement-signatories) and scientists who have contributed to the on-going development of this community resource [https://doi.org/10.1093/jamia/ocaa196]."

For publication submission information, please see the Publication Review Page

Sign up for the N3Connect Bulletin.